Loading…
Acute vasoreactivity testing during right heart catheterization in chronic thromboembolic pulmonary hypertension: Results from the pulmonary vascular disease phenomics study
Chronic thromboembolic pulmonary hypertension (CTEPH) is believed to involve both vascular obstruction and vasoconstriction; hence, pulmonary vasodilators such as riociguat may be beneficial. Acute vasoreactivity testing (AVT) is seldom performed routinely in CTEPH patients, so there is limited unde...
Main Authors: | Frantz, Robert P., Leopold, Jane A., Hassoun, Paul M., Hemnes, Anna R., Horn, Evelyn M., Mathai, Stephen C., Rischard, Franz P., Larive, A. Brett, Tang, W.h. Wilson, Park, Margaret M., Hill, Nicholas S., Rosenzweig, Erika B. |
---|---|
Format: | Online Article Text |
Language: | English |
Published: |
John Wiley and Sons Inc.
2023
|
Subjects: | |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9817070/ https://www.ncbi.nlm.nih.gov/pubmed/36618713 http://dx.doi.org/10.1002/pul2.12181 |
Similar Items
-
Frequency of acute vasodilator response (AVR) in incident and prevalent patients with pulmonary arterial hypertension: Results from the pulmonary vascular disease phenomics study
by: Naranjo, Mario, et al.
Published: (2023) -
Vasoreactive phenotype in children with pulmonary arterial hypertension and syncope
by: Linder, Alexandra N., et al.
Published: (2022) -
Clinical Study of Acute Vasoreactivity Testing in Patients with Chronic Thromboembolic Pulmonary Hypertension
by: Xu, Qi-Xia, et al.
Published: (2017) -
Cholesterol: A Novel Regulator of Vasoreactivity in Pulmonary
Arteries
by: Grimmer, Benjamin, et al.
Published: (2020) -
Prognostic value of longitudinal vasoreactivity in pediatric pulmonary hypertension
by: Evers, Patrick D., et al.
Published: (2022)